|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
D01.7 |
Carcinoma in situ of other specified digestive organs
|
D017 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 39.20%
|
18.99%
|
14.81%
|
7.14%
|
5.92%
|
2.79%
|
2.44%
|
1.39%
|
2.26%
|
1.74%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for D01.7*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
74183
|
MRI ABD W/O CNTR FLWD CNTR |
34
|
34
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
30
|
30
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
22
|
22
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
21
|
1,761
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
19
|
19
|
|
82565
|
ASSAY OF CREATININE |
18
|
18
|
|
80053
|
COMPREHEN METABOLIC PANEL |
15
|
15
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
14
|
14
|
|
G1004
|
CDSM NDSC |
13
|
15
|
|
86301
|
IMMUNOASSAY TUMOR CA 19-9 |
11
|
11
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
10
|
339
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
9
|
9
|
|
99213
|
OFFICE O/P EST LOW 20 MIN |
8
|
8
|
|
A9577
|
INJ MULTIHANCE |
8
|
93
|
|
A9585
|
GADOBUTROL INJECTION |
8
|
670
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
7
|
7
|
|
71260
|
CT THORAX DX C+ |
6
|
6
|
|
A9579
|
GAD-BASE MR CONTRAST NOS,1ML |
6
|
90
|
|
A9575
|
INJ GADOTERATE MEGLUMI 0.1ML |
6
|
829
|
|
84520
|
ASSAY OF UREA NITROGEN |
5
|
5
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
D01.7 related to the following DRG Codes:
374-376
|
